Drug Efficacy

X ray illustration of a running person with pain in knee joint with blue background

Biotech

Novartis culls ph. 2 knee pain trial testing anti-ADAMTS-5 asset

Novartis discontinued the study after an interim analysis found an “insufficient effect on pain relief,” a spokesperson said.

Gabrielle Masson Apr 16, 2025 2:55pm

handshake over a desk with computers and someone taking notes

Parker Institute teams up with Xyphos to tame CAR-Ts

Oct 19, 2018 8:26am